INVENGO(SZ:002161) Mei Ri Jing Ji Xin Wen·2025-11-19 01:01Core Viewpoint - The company is actively expanding its business in medical reagent management, collaboration with ADIDAS, and urban rail transit solutions, indicating a focus on innovative technology applications and market growth. Group 1: Medical Reagent Management - The company has developed a comprehensive management solution for medical reagents, enabling automated and intelligent management throughout the entire process from production to sales. This business is identified as a new growth point, with ongoing market expansion [1]. Group 2: Collaboration with ADIDAS - The collaboration with ADIDAS is progressing well, with the company's products being utilized in several stores across South China, East China, and Southwest China [1]. Group 3: Urban Rail Transit Solutions - The company has developed a series of RFID technology-based products and solutions for urban subway systems, including high-interference-resistant RFID tags, specialized reading and writing devices, and positioning systems. Projects related to urban rail transit are advancing as planned [1].